💥’Physical Examination of the Dialysis Vascular Access’ - Tweetorial Let’s first review the: ⚡️Anatomy of the Vascular Access ⚡️Vascular Access-related complications 1/ ASDIN Renal Fellow Network #VascularAccessPearls

And the stunning 😍 VA by Dominique Tomacruz, MD

Respiratory acidosis and respiratory alkalosis: Core Curriculum 2023 from AJKD #Nephpearls pubmed.ncbi.nlm.nih.gov/37341662/

Should mycophenolate mofetil be used in immunoglobulin A nephropathy? bit.ly/45pFn5C

Implementation of the Kidney Failure Risk Equation (#KFRE) in a U.S. Nephrology Clinic #VisualAbstract by Dominique Tomacruz, MD kireports.org/article/S2468-… @Patel_DipalM Bryce C Morgan Grams Chirag Parikh @DrDeidraCrews

Exciting Updates for WCN'24: New abstract deadline & Scientific Program now online! 💥 New deadline for abstract submission: November 15 at midnight CET ow.ly/U6l850Q2E2E 💥 Scientific Program now available: WCN’24 brings you a four-day program packed with scientific and

Stop by posters 52 and 625 and learn about #conflict, which are many and increasing, on #dialysis operations and frameworks for improvement #KidneyWk American Society of Nephrology Mayo Clinic Transplant Mayo Clinic Arizona Nephrology & Transplant Hopkins Nephrology

Nice summary of tubular nephrotoxins by Harish Seethapathy at GlomCon :

Optimization of #Rituximab Therapy in Adult patients with #PLA2R1 Associated #MembranousNephropathy with Artificial Intelligence #AI #VisualAbstract by Dominique Tomacruz, MD kireports.org/article/S2468-…

Clinical Practice Guideline for the Evaluation and Management of CKD ca. 2024 from KDIGO Kidney International #WorldKidneyDay 2️⃣🌐2️⃣4️⃣ #Nephpearls 👉🏼 kdigo.org/guidelines/ckd…

APPLAUSE-IgAN: Iptacopan for IgA Nephropathy (IgAN) from KIReports #GlomConHawaii 🇺🇸 #Nephpearls How it started How it’s going 👉🏼 pubmed.ncbi.nlm.nih.gov/37180505/

Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial ca. 2024 from @CJASN #Nephpearls #KidneyWk #BestofCJASN #VisualAbstract by Dominique Tomacruz, MD 👉 pubmed.ncbi.nlm.nih.gov/38349776/

Huge elephant in the room - persuading patients to take a multitude of drugs for what for many is an asymptomatic condition (very different from heart failure) & often on top of disease modifying medications… We need to understand this and develop best combinations and support